• Non ci sono risultati.

Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications.

N/A
N/A
Protected

Academic year: 2021

Condividi "Astragalus membranaceus and oxaliplatin-induced neuropathy: pain relief and prevention of nervous tissue modifications."

Copied!
1
0
0

Testo completo

(1)

IJA E

Vol. 119, n. 1 (Supplement): 147, 2014

© 2014 Firenze University Press http://www.fupress.com/ijae

ITALIAN JOU R NAL OF ANATOMY AN D EM B RYOLOGY

Astragalus membranaceus and oxaliplatin-induced

neuropathy: pain relief and prevention of nervous

tissue modifications

Alessandra Pacini1, Laura Micheli2, Lorenzo Di Cesare Mannelli2, Alessandro Mugelli2, Carla

Ghelardini2

1 School of Human Health, Dept. of Experimental and Clinical Medicine - Anatomy and Histology Section, University of Florence, Italy

2 School of Human Health, Dept. NEUROFARBA - Pharmacology and Toxicology Section, University of Florence, Italy

Neurotoxicity is the limiting side effect of the anticancer agent oxaliplatin. A tan-gled panel of symptoms, sensory loss, paresthesia, dysesthesia, pain may be disabling for patients adversely affecting quality of life. Pharmacological treatments demon-strating a therapeutic effect on oxaliplatin’s cumulative neurotoxicity are unsatisfac-tory and limited to symptomatic effects.

Astragalus membranaceus is an adaptogenic herb from the traditional Chinese

medicine. Aimed to study the antineuropathic profile of this plant, a hydroalcohol-ic extract from selected roots of A. membranaceus was obtained and characterized. A.

membranaceus extract was tested in a rat model of painful oxaliplatin-induced

neu-ropathy (2.4 mgkg-1 intraperitoneally, daily for 21 days). The extract was administered

per os (300 mgkg-1) once a day, starting from the first day of oxaliplatin injection until

the 20th. On day 21A. membranaceus extract treatment was able to significantly reduce

oxaliplatin-dependent pain, when evaluated as an increase on suprathreshold stimu-lation (hyperalgesia-related measure) or as a decrease in pain threshold (allodynia-related measure). The extract strongly prevented the serious nephro- and hepato-tox-icity induced by repeated treatment with the anticancer drug. In the nervous system the hydroalcoholic extract reduced the morphometric alterations induced by oxalipl-atin in the dorsal root ganglia, and significantly prevented the changes in the acti-vating transcription factor 3 and in the phosphorylated heavy chain of neurofilament expression levels both in nerves and ganglia. In the dorsal horn of the spinal cord and in pain related cerebral areas A. membranaceus extract prevented the oxaliplatin-induced increase of glial density.

The hydroalcoholic extract of Astragalus membranaceus relieves pain and promotes the rescue mechanisms that protect nervous tissue from the damages triggering chronic pain. A safe profile strongly suggests the usefulness of this natural product in oxaliplatin-induced neuropathy.

Keywords

Riferimenti

Documenti correlati

Qui siamo nella città e nella campagna contemporaneamente dove le misure di un tempo veloce si devono adattare a quelle di un tempo più lento, dove le regole che hanno defini- to

Moreover, alteration of sequences including the TATA box (mutant LS2), and the region surrounding the transcription start site (mutant LS1) results in a substantial reduction of

(…) aber dieser warf sich wie eine Bestie über sie, er spreizte ihre Glie- der, zerrte an ihrer Haut, und dann nahm er sie roh, ging roh mit ihr um, wo sie doch schmal und zart war,

t 98 t) neurome lanin is characterized by the pres- ence of both lipofuscin and melanin com po nents. l t see med therefo re of intere st to extend our research to

Poster alla XXII edizione dello European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Londra, 31 marzo-3 aprile 2012. Microbiology of cardiac

In the literature, there are many studies focused on the antineoplastic-induced alteration of microtubule organization (and consequently, fast axonal transport defects) while very

A few years later it was demonstrated that large differences in the relative potencies of kainate (a ‘glutamate analogue’) and N-methyl-d-aspartate (NMDA, an ‘aspartate